Home
APLT
APLT News

Latest Applied Therapeutics Inc. (APLT) News on August 25, 2025

MT Newswires

2 months ago

Applied Therapeutics Promotes Evan Bailey to Chief Medical Officer

Applied Therapeutics Announces Key Leadership Appointments

GlobeNewswire

2 months ago

Applied Therapeutics Announces Key Leadership Appointments

Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

GlobeNewswire

3 months ago

Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

Applied Therapeutics Reports First Quarter 2025 Financial Results

GlobeNewswire

3 months ago

Applied Therapeutics Reports First Quarter 2025 Financial Results

Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

GlobeNewswire

4 months ago

Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results

GlobeNewswire

4 months ago

Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results

Russell 2000 Enters Bear Market With Small Caps Stung by Tariffs

Bloomberg

5 months ago

Russell 2000 Enters Bear Market With Small Caps Stung by Tariffs

Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission

GlobeNewswire

5 months ago

Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission

Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer

GlobeNewswire

5 months ago

Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer

3 Penny Stocks With At Least $50M Market Cap

Simply Wall St.

5 months ago

3 Penny Stocks With At Least $50M Market Cap

Why pharma is still far from a treatment for galactosemia

Clinical Trials Arena

6 months ago

Why pharma is still far from a treatment for galactosemia

BeiGene (ONC) Soars 3.2%: Is Further Upside Left in the Stock?

Zacks

6 months ago

BeiGene (ONC) Soars 3.2%: Is Further Upside Left in the Stock?

Applied Therapeutics Appoints Reena Thomas Colacot as Vice President and Head of Quality

GlobeNewswire

7 months ago

Applied Therapeutics Appoints Reena Thomas Colacot as Vice President and Head of Quality

Is Applied Therapeutics (APLT) the Best Penny Stock to Invest In According to Media?

Insider Monkey

8 months ago

Is Applied Therapeutics (APLT) the Best Penny Stock to Invest In According to Media?

Here’s Why Applied Therapeutics, Inc. (NASDAQ:APLT) Is Among the Best Diabetes Stocks to Buy Under $10

Insider Monkey

8 months ago

Here’s Why Applied Therapeutics, Inc. (NASDAQ:APLT) Is Among the Best Diabetes Stocks to Buy Under $10

MT Newswires

8 months ago

William Blair Downgrades Applied Therapeutics to Market Perform From Outperform

Penny Stock Applied Therapeutics' FDA Troubles Trigger Investor Lawsuit, Shareholders Claim Deception Over Govorestat Clinical Data

Benzinga

8 months ago

Penny Stock Applied Therapeutics' FDA Troubles Trigger Investor Lawsuit, Shareholders Claim Deception Over Govorestat Clinical Data

MT Newswires

8 months ago

Applied Therapeutics Names John Johnson as Executive Chair, Les Funtleyder as Interim CEO

MT Newswires

8 months ago

RBC Cuts Price Target on Applied Therapeutics to $1.50 From $4, Keeps Sector Perform, Speculative Risk

Applied Therapeutics Appoints John H. Johnson as Executive Chairman

GlobeNewswire

8 months ago

Applied Therapeutics Appoints John H. Johnson as Executive Chairman

Will Applied Therapeutics (NASDAQ:APLT) Spend Its Cash Wisely?

Simply Wall St.

9 months ago

Will Applied Therapeutics (NASDAQ:APLT) Spend Its Cash Wisely?

MT Newswires

9 months ago

Applied Therapeutics Faces Uncertainty After US FDA Rejects NDA for Govorestat in Galactosemia, UBS Says

Company News for Dec 2, 2024

Zacks

9 months ago

Company News for Dec 2, 2024

MT Newswires

9 months ago

UBS Downgrades Applied Therapeutics to Neutral From Buy, Cuts Price Target to $2 From $13

Applied Therapeutics CRL a ‘major setback,’ says William Blair

TipRanks

9 months ago

Applied Therapeutics CRL a ‘major setback,’ says William Blair

Applied Therapeutics downgraded to Sector Perform from Outperform at RBC

TipRanks

9 months ago

Applied Therapeutics downgraded to Sector Perform from Outperform at RBC

FDA Rejects Applied Therapeutics' NDA for Govorestat, Citing Flaws; Shares Plunge 76%

GuruFocus.com

9 months ago

FDA Rejects Applied Therapeutics' NDA for Govorestat, Citing Flaws; Shares Plunge 76%

Biotech Stock Roundup: BBIO Stock Up on Drug Approval, SAVA, APLT Plunge on Setbacks & More

Zacks

9 months ago

Biotech Stock Roundup: BBIO Stock Up on Drug Approval, SAVA, APLT Plunge on Setbacks & More

MT Newswires

9 months ago

Top Midday Decliners

MT Newswires

9 months ago

Sector Update: Health Care Stocks Rise in Afternoon Trading

Applied Therapeutics' Govorestat Faces 'Significant' Uncertainty in Galactosemia Treatment After FDA Rejection, RBC Says

MT Newswires

9 months ago

Applied Therapeutics' Govorestat Faces 'Significant' Uncertainty in Galactosemia Treatment After FDA Rejection, RBC Says

Applied Therapeutics Stock Plummets 73%. The FDA Delivers This Crushing Blow.

Barrons.com

9 months ago

Applied Therapeutics Stock Plummets 73%. The FDA Delivers This Crushing Blow.

Applied Therapeutics Stock Plummets After FDA Rejects Metabolic Disease Drug

Investopedia

9 months ago

Applied Therapeutics Stock Plummets After FDA Rejects Metabolic Disease Drug

MT Newswires

9 months ago

Applied Therapeutics' Govorestat Faces Unclear Regulatory Path After FDA Rejection, RBC Says

MT Newswires

9 months ago

Sector Update: Health Care Stocks Advance Pre-Bell Friday

MT Newswires

9 months ago

Sector Update: Health Care

Investing.com

9 months ago

RBC downgrades Applied Therapeutics as FDA rejects Govorestat, hacks price target

MT Newswires

9 months ago

Update: Applied Therapeutics' Shares Fall After FDA Rejects NDA for Govorestat in Classic Galactosemia

MT Newswires

9 months ago

Top Premarket Decliners

MT Newswires

9 months ago

RBC Downgrades Applied Therapeutics to Sector Perform From Outperform, Cuts Price Target to $4 From $12, Keeps Speculative Risk

APLT Stock Plunges 77% After FDA Issues CRL for Galactosemia Drug NDA

Zacks

9 months ago

APLT Stock Plunges 77% After FDA Issues CRL for Galactosemia Drug NDA

Wait for galactosemia therapy goes on after FDA shuns Applied Therapeutics’ govorestat

Pharmaceutical Technology

9 months ago

Wait for galactosemia therapy goes on after FDA shuns Applied Therapeutics’ govorestat

MT Newswires

9 months ago

US FDA Rejects Applied Therapeutics' New Drug Application for Govorestat in Classic Galactosemia

Applied Therapeutics Receives Complete Response Letter from U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia

GlobeNewswire

9 months ago

Applied Therapeutics Receives Complete Response Letter from U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia

Applied Therapeutics Reports Third Quarter 2024 Financial Results

GlobeNewswire

10 months ago

Applied Therapeutics Reports Third Quarter 2024 Financial Results

Applied Therapeutics to Present at the 2024 UBS Global Healthcare Conference

GlobeNewswire

10 months ago

Applied Therapeutics to Present at the 2024 UBS Global Healthcare Conference

Applied Therapeutics (APLT) Upgraded to Buy: Here's What You Should Know

Zacks

10 months ago

Applied Therapeutics (APLT) Upgraded to Buy: Here's What You Should Know

Is Applied Therapeutics (APLT) Outperforming Other Medical Stocks This Year?

Zacks

10 months ago

Is Applied Therapeutics (APLT) Outperforming Other Medical Stocks This Year?

Are Medical Stocks Lagging Applied Therapeutics (APLT) This Year?

Zacks

10 months ago

Are Medical Stocks Lagging Applied Therapeutics (APLT) This Year?

Is Applied Therapeutics (APLT) Stock Outpacing Its Medical Peers This Year?

Zacks

a year ago

Is Applied Therapeutics (APLT) Stock Outpacing Its Medical Peers This Year?

All You Need to Know About Applied Therapeutics (APLT) Rating Upgrade to Buy

Zacks

a year ago

All You Need to Know About Applied Therapeutics (APLT) Rating Upgrade to Buy

APLT Stock Soars 69% on Positive Update on Galactosemia Drug NDA

Zacks

a year ago

APLT Stock Soars 69% on Positive Update on Galactosemia Drug NDA

MT Newswires

a year ago

Applied Therapeutics Shares Rise After Classic Galactosemia New Drug Application Review Update

MT Newswires

a year ago

Top Midday Gainers

Why Applied Therapeutics Stock Is Skyrocketing Today

Motley Fool

a year ago

Why Applied Therapeutics Stock Is Skyrocketing Today

Applied Therapeutics Stock Soars As FDA Scraps Panel Meeting For Its Inherited Metabolic Disorder Drug

Benzinga

a year ago

Applied Therapeutics Stock Soars As FDA Scraps Panel Meeting For Its Inherited Metabolic Disorder Drug

MT Newswires

a year ago

Top Premarket Gainers

Applied Therapeutics Provides Regulatory Update on Govorestat for the Treatment of Classic Galactosemia

GlobeNewswire

a year ago

Applied Therapeutics Provides Regulatory Update on Govorestat for the Treatment of Classic Galactosemia

Applied Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire

a year ago

Applied Therapeutics to Participate in Upcoming Investor Conferences

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 08/15/2024

Applied Therapeutics Reports Second Quarter 2024 Financial Results

GlobeNewswire

a year ago

Applied Therapeutics Reports Second Quarter 2024 Financial Results

Applied Therapeutics, Inc. (NASDAQ:APLT): When Will It Breakeven?

Simply Wall St.

a year ago

Applied Therapeutics, Inc. (NASDAQ:APLT): When Will It Breakeven?

Rare Disease-Focused Applied Therapeutics' Lead Candidate Govorestat Has Blockbuster Potential, Analyst Sees 140% Stock Upside

Benzinga

a year ago

Rare Disease-Focused Applied Therapeutics' Lead Candidate Govorestat Has Blockbuster Potential, Analyst Sees 140% Stock Upside

MT Newswires

a year ago

William Blair Initiates Applied Therapeutics at Outperform

MT Newswires

a year ago

Applied Therapeutics Joins Russell 3000 Index

Applied Therapeutics Added to Russell 3000® Index

GlobeNewswire

a year ago

Applied Therapeutics Added to Russell 3000® Index

Why Is Applied Therapeutics, Inc. (APLT) the Best Biotech Penny Stock to Buy Now?

Insider Monkey

a year ago

Why Is Applied Therapeutics, Inc. (APLT) the Best Biotech Penny Stock to Buy Now?

Here's Why We're Not Too Worried About Applied Therapeutics' (NASDAQ:APLT) Cash Burn Situation

Simply Wall St.

a year ago

Here's Why We're Not Too Worried About Applied Therapeutics' (NASDAQ:APLT) Cash Burn Situation

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

GOBankingRates

a year ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller

AFP

a year ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up

AFP

a year ago

Italy beat Bosnia in final Euros warm-up

Trump loyalists proud to support 'felon' at Las Vegas rally

AFP

a year ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

Business Insider

a year ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women

Insider Monkey

a year ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Reuters

a year ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Insider Monkey

a year ago

Best Date Night Fragrance in 2024

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Simply Wall St.

a year ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North

AFP

a year ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

Simply Wall St.

a year ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Simply Wall St.

a year ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Barrons.com

a year ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

Simply Wall St.

a year ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Simply Wall St.

a year ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Should You Buy OVB Holding AG (ETR:O4B) For Its Upcoming Dividend?

Simply Wall St.

a year ago

Should You Buy OVB Holding AG (ETR:O4B) For Its Upcoming Dividend?

Applied Therapeutics Inc (APLT) Reports Q1 2024 Earnings: A Deep Dive into Financials and ...

GuruFocus.com

a year ago

Applied Therapeutics Inc (APLT) Reports Q1 2024 Earnings: A Deep Dive into Financials and ...

Applied Therapeutics Reports First Quarter 2024 Financial Results

GlobeNewswire

a year ago

Applied Therapeutics Reports First Quarter 2024 Financial Results

Applied Therapeutics to Present at the 2024 RBC Capital Markets Global Healthcare Conference

GlobeNewswire

a year ago

Applied Therapeutics to Present at the 2024 RBC Capital Markets Global Healthcare Conference

Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer

GlobeNewswire

a year ago

Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer

Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024

GlobeNewswire

a year ago

Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024

Reuters

a year ago

UPDATE 1-US FDA extends review of Applied Therapeutics' genetic disease drug

Reuters

a year ago

US FDA extends review of Applied Therapeutics' genetic disease drug

Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia

GlobeNewswire

a year ago

Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia

Applied Therapeutics (APLT) Surges 124% in a Month: Here's Why

Zacks

a year ago

Applied Therapeutics (APLT) Surges 124% in a Month: Here's Why

Applied Therapeutics Inc (APLT) Announces Year-End 2023 Financial Results and Clinical Progress

GuruFocus.com

a year ago

Applied Therapeutics Inc (APLT) Announces Year-End 2023 Financial Results and Clinical Progress

Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results

GlobeNewswire

a year ago

Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results

FDA Grants Review Date For Applied Therapeutics' First Commercial Product For Rare Metabolic Disorder

Benzinga

a year ago

FDA Grants Review Date For Applied Therapeutics' First Commercial Product For Rare Metabolic Disorder

Applied Therapeutics Announces $100 Million Private Placement

GlobeNewswire

a year ago

Applied Therapeutics Announces $100 Million Private Placement

Applied Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Govorestat for the Treatment of Classic Galactosemia

GlobeNewswire

a year ago

Applied Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Govorestat for the Treatment of Classic Galactosemia

13 Best Booming Stocks to Buy Right Now

Insider Monkey

2 years ago

13 Best Booming Stocks to Buy Right Now

Applied Therapeutics Announces Positive Results from 12-month Interim Analysis of Govorestat (AT-007) in the Ongoing INSPIRE Phase 3 Trial in Sorbitol Dehydrogenase (SORD) Deficiency

GlobeNewswire

2 years ago

Applied Therapeutics Announces Positive Results from 12-month Interim Analysis of Govorestat (AT-007) in the Ongoing INSPIRE Phase 3 Trial in Sorbitol Dehydrogenase (SORD) Deficiency

Share on Social Networks: